Accessibility Menu
 

Cannabis Bioscience International

(OTC) CHNC

Current PriceN/A
Market CapN/A
Since IPO (2018)-98%
5 Year-88%
1 Year-38%
1 Month+0%

Cannabis Bioscience International Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$127.35K

Net Income (TTM)

$371.66K

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

CHNC News

No articles available.

CHNC: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cannabis Bioscience International

Industry

Life Sciences Tools and Services

Employees

2

CEO

Dante Picazo

Headquarters

Houston, TX 91789, US

CHNC Financials

Key Financial Metrics (TTM)

Gross Margin

67%

Operating Margin

-3%

Net Income Margin

-3%

Return on Equity

2%

Return on Capital

35%

Return on Assets

-17%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Short Interest

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$262.92K

Operating Income

$381.26K

EBITDA

$381.26K

Operating Cash Flow

$329.63K

Capital Expenditure

$0.00

Free Cash Flow

$329.63K

Cash & ST Invst.

$12.95K

Total Debt

$116.63K

Cannabis Bioscience International Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$53.27K

-28.3%

Gross Profit

$42.77K

-35.6%

Gross Margin

80.29%

N/A

Market Cap

N/A

N/A

Market Cap/Employee

N/A

N/A

Employees

2

N/A

Net Income

$116.97K

-47.1%

EBITDA

$116.97K

-125.7%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$111.59K

+46.0%

Accounts Receivable

$21.81K

+57.8%

Inventory

$0.00

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$111.72K

-14.2%

Return on Assets

-16.79%

N/A

Return on Invested Capital

35.20%

N/A

Free Cash Flow

$5.49K

+92.5%

Operating Cash Flow

$5.49K

+92.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ACRHFAcreage Holdings, Inc.
$0.00-11.11%
ACRDFAcreage Holdings, Inc.
$0.12+2.52%
IVITFInvictus MD Strategies Corp.
$0.00+9900.00%
HDRPFEpsilon Healthcare Limited
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$41.68+0.10%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.55-0.11%
QQQInvesco QQQ Trust
$577.18+0.03%
APLSApellis Pharmaceuticals
$40.23+1.35%

Questions About CHNC

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.